COMING UP-Reuters interview with Merck drugs head

FRANKFURT, Sept 3 | Thu Sep 3, 2009 5:21am EDT

FRANKFURT, Sept 3 (Reuters) - Reuters has interviewed the head of Merck KGaA's (MRCG.DE) pharmaceuticals business, Elmar Schnee, who discusses prospects for the Erbitux and Cladribine drugs.

The interview will be published around 0930 GMT.

Related Quotes and News

Company
Price
Related News
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.